Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Common and Preferred Stock

	December 31, 2023	December 31, 2022
Common Stock
Number of shares authorized	10,000,000	10,000,000
Number of shares issued and outstanding	5,050,000	5,050,000

	December 31, 2023	December 31, 2022
Preferred Stock
Number of shares authorized	250,000,000	250,000,000
Number of shares issued and outstanding(a)
Series A	1,000,000	1,000,000
Series B	500,000	500,000
Series C	500,000	500,000

_________________

(a)Issued at a liquidation preference of $1,000 per share.

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table summarizes the significant components of accumulated other comprehensive income (loss):

	Years Ended December 31,
	2023		2022		2021
Unrealized gain (loss) on hedges
Beginning balance	$	(21)	$	(77)	$	(157)
Change in value of hedges, net of tax	18		55		80
Ending balance	(3)		(21)		(77)
Defined benefit plans
Beginning balance	1		1		1
Unrealized gain (loss) on subsidiary pension, net of tax	—		1		—
Ending balance	1		1		1
Foreign currency translation adjustment
Beginning balance	(1,352)		(1,197)		(1,153)
Translation gain (loss), net of tax	147		(156)		(44)
Ending balance	(1,206)		(1,352)		(1,197)
Total accumulated other comprehensive income (loss)	$	(1,208)	$	(1,373)	$	(1,273)